Guangdong Kanghua Healthcare Co., Ltd. (3689.HK)
HKD 2.16
(-1.37%)
HKD 2.16
(-1.37%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.12 Billion CNY | -7.34% |
| 2022 | 1.21 Billion CNY | -1.09% |
| 2021 | 1.23 Billion CNY | 17.56% |
| 2020 | 1.04 Billion CNY | -7.04% |
| 2019 | 1.12 Billion CNY | 62.29% |
| 2018 | 693.57 Million CNY | 56.57% |
| 2017 | 442.99 Million CNY | 5.24% |
| 2016 | 420.93 Million CNY | -51.01% |
| 2015 | 859.17 Million CNY | -50.81% |
| 2014 | 1.74 Billion CNY | 0.49% |
| 2013 | 1.73 Billion CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.22 Billion CNY | 0.0% |
| 2024 Q1 | 1.22 Billion CNY | 8.7% |
| 2023 Q2 | 1.11 Billion CNY | 0.0% |
| 2023 FY | 1.12 Billion CNY | -7.34% |
| 2023 Q4 | 1.12 Billion CNY | 0.0% |
| 2023 Q1 | 1.11 Billion CNY | -8.4% |
| 2023 Q3 | 1.12 Billion CNY | 1.15% |
| 2022 Q3 | 1.2 Billion CNY | -3.16% |
| 2022 Q4 | 1.21 Billion CNY | 1.0% |
| 2022 Q2 | 1.24 Billion CNY | 0.0% |
| 2022 Q1 | 1.24 Billion CNY | 1.14% |
| 2022 FY | 1.21 Billion CNY | -1.09% |
| 2021 FY | 1.23 Billion CNY | 17.56% |
| 2021 Q2 | 1.21 Billion CNY | 0.0% |
| 2021 Q1 | 1.21 Billion CNY | 15.97% |
| 2021 Q3 | 1.23 Billion CNY | 1.37% |
| 2021 Q4 | 1.23 Billion CNY | 0.0% |
| 2020 Q3 | 1.04 Billion CNY | -1.01% |
| 2020 Q1 | 1.05 Billion CNY | -6.08% |
| 2020 FY | 1.04 Billion CNY | -7.04% |
| 2020 Q2 | 1.05 Billion CNY | 0.0% |
| 2020 Q4 | 1.04 Billion CNY | 0.0% |
| 2019 Q2 | 1.04 Billion CNY | 0.0% |
| 2019 Q4 | 1.12 Billion CNY | 0.0% |
| 2019 Q3 | 1.12 Billion CNY | 7.23% |
| 2019 FY | 1.12 Billion CNY | 62.29% |
| 2019 Q1 | 1.04 Billion CNY | 51.34% |
| 2018 Q2 | 443.03 Million CNY | 0.0% |
| 2018 FY | 693.57 Million CNY | 56.57% |
| 2018 Q4 | 693.57 Million CNY | 3.04% |
| 2018 Q3 | 673.09 Million CNY | 51.93% |
| 2018 Q1 | 443.03 Million CNY | 0.01% |
| 2017 Q2 | 394.05 Million CNY | 0.0% |
| 2017 Q3 | 442.99 Million CNY | 12.42% |
| 2017 Q4 | 442.99 Million CNY | 0.0% |
| 2017 FY | 442.99 Million CNY | 5.24% |
| 2017 Q1 | 394.05 Million CNY | -6.39% |
| 2016 Q3 | 420.93 Million CNY | 0.0% |
| 2016 Q1 | 757.39 Million CNY | 0.0% |
| 2016 Q4 | 420.93 Million CNY | 0.0% |
| 2016 FY | 420.93 Million CNY | -51.01% |
| 2015 FY | 859.17 Million CNY | -50.81% |
| 2014 FY | 1.74 Billion CNY | 0.49% |
| 2013 FY | 1.73 Billion CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aidigong Maternal & Child Health Limited | 1.2 Billion HKD | 6.374% |
| UMP Healthcare Holdings Limited | 362.14 Million HKD | -211.328% |
| Human Health Holdings Limited | 289.7 Million HKD | -289.172% |
| EuroEyes International Eye Clinic Limited | 588.09 Million HKD | -91.715% |
| Kato (Hong Kong) Holdings Limited | 428.77 Million HKD | -162.949% |
| Bamboos Health Care Holdings Limited | 99.73 Million HKD | -1030.443% |
| Beijing Health (Holdings) Limited | 223.82 Million HKD | -403.728% |
| C-MER Eye Care Holdings Limited | 755.34 Million HKD | -49.263% |
| Town Health International Medical Group Limited | 881.82 Million HKD | -27.856% |
| Medicskin Holdings Limited | 32.47 Million HKD | -3371.348% |
| Hang Chi Holdings Limited | 100.92 Million HKD | -1017.081% |